CHE vs. MD
Compare and contrast key facts about Chemed Corporation (CHE) and MEDNAX, Inc. (MD).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CHE or MD.
Correlation
The correlation between CHE and MD is -0.40. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.
Performance
CHE vs. MD - Performance Comparison
Loading data...
Key characteristics
CHE:
12.73%
MD:
93.54%
CHE:
-1.45%
MD:
-0.90%
CHE:
-1.25%
MD:
0.00%
Fundamentals
CHE:
$8.34B
MD:
$1.25B
CHE:
$20.53
MD:
-$1.00
CHE:
2.26
MD:
0.88
CHE:
3.35
MD:
0.63
CHE:
7.06
MD:
1.56
CHE:
$2.49B
MD:
$1.98B
CHE:
$834.93M
MD:
$453.32M
CHE:
$452.20M
MD:
-$57.10M
Returns By Period
CHE
N/A
N/A
N/A
N/A
N/A
N/A
MD
N/A
N/A
N/A
N/A
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CHE vs. MD — Risk-Adjusted Performance Rank
CHE
MD
CHE vs. MD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Chemed Corporation (CHE) and MEDNAX, Inc. (MD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
CHE vs. MD - Dividend Comparison
CHE's dividend yield for the trailing twelve months is around 0.33%, while MD has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHE Chemed Corporation | 0.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MD MEDNAX, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
CHE vs. MD - Drawdown Comparison
The maximum CHE drawdown since its inception was -1.45%, which is greater than MD's maximum drawdown of -0.90%. Use the drawdown chart below to compare losses from any high point for CHE and MD. For additional features, visit the drawdowns tool.
Loading data...
Volatility
CHE vs. MD - Volatility Comparison
Loading data...
Financials
CHE vs. MD - Financials Comparison
This section allows you to compare key financial metrics between Chemed Corporation and MEDNAX, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CHE vs. MD - Profitability Comparison
CHE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Chemed Corporation reported a gross profit of 200.40M and revenue of 646.94M. Therefore, the gross margin over that period was 31.0%.
MD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, MEDNAX, Inc. reported a gross profit of 102.64M and revenue of 458.36M. Therefore, the gross margin over that period was 22.4%.
CHE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Chemed Corporation reported an operating income of 94.76M and revenue of 646.94M, resulting in an operating margin of 14.7%.
MD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, MEDNAX, Inc. reported an operating income of 38.71M and revenue of 458.36M, resulting in an operating margin of 8.4%.
CHE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Chemed Corporation reported a net income of 71.76M and revenue of 646.94M, resulting in a net margin of 11.1%.
MD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, MEDNAX, Inc. reported a net income of 20.74M and revenue of 458.36M, resulting in a net margin of 4.5%.